School of Medicine


Showing 101-200 of 313 Results

  • Anna Lembke, MD

    Anna Lembke, MD

    Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology-Adult)

    BioDr. Anna Lembke received her undergraduate degree in Humanities from Yale University and her medical degree from Stanford University. She is currently Professor and Medical Director of Addiction Medicine, Stanford University School of Medicine. She is also Program Director of the Stanford Addiction Medicine Fellowship, Chief of the Stanford Addiction Medicine Dual Diagnosis Clinic, and a diplomate of the American Board of Psychiatry and Neurology and the American Board of Addiction Medicine.

    In 2016, she published "Drug Dealer, MD – How Doctors Were Duped, Patients Got Hooked, and Why It’s So Hard to Stop" (Johns Hopkins University Press, 2016), highlighted in the New York Times as one of the top five books to read to understand the opioid epidemic (Zuger, 2018).

    Dr. Lembke appeared in the Netflix documentary The Social Dilemma, an unvarnished look at the impact of social media on our lives.

    Her latest book, "Dopamine Nation: Finding Balance in the Age of Indulgence" (Dutton/Penguin Random House, August 2021) was an instant New York Times and Los Angeles Times bestseller and has been translated into 30 languages. It combines the neuroscience of addiction with the wisdom of recovery to explore the problem of compulsive overconsumption in a dopamine-overloaded world.

  • Hendrikus Lemmens

    Hendrikus Lemmens

    Professor of Anesthesiology, Perioperative and Pain Medicine

    Current Research and Scholarly InterestsClinical Pharmacology of Anesthetics
    Morbid Obesity
    Impedance Cardiography

  • Theodore Leng, MD, FACS

    Theodore Leng, MD, FACS

    Associate Professor of Ophthalmology and, by courtesy, of Anesthesiology, Perioperative and Pain Medicine (Adult MSD)

    Current Research and Scholarly InterestsDr. Leng was the first surgeon in California to perform a subretinal transplant of adult neural stem cells into patients with macular degeneration and is actively researching cellular, biologic and laser-based therapies for macular degeneration. He also has an active program in imaging informatics and deep learning to perform big data analyses of retinal scans to identify patients who are at risk for retinal disease deterioration. The end goal is earlier detection and rapid treatment to maximize visual outcomes.

    Dr. Leng is considered a leading expert on optical coherence tomography (OCT) and OCT-based angiography (OCTA), a non-invasive and non-contact imaging technique for the retina. He is also considered a key opinion leader in artificial intelligence and data science.

  • Marc Leon MD, PhD (aka Hongliang Liang)

    Marc Leon MD, PhD (aka Hongliang Liang)

    Clinical Assistant Professor, Cardiothoracic Surgery

    BioMarc Leon (aka Hongliang Liang) M.D. & Ph.D. previously worked as Chief Surgeon, Associate Professor of Cardiovascular Surgery, and Director of the Division of Coronary Artery Surgery at Xijing Hospital in Xi'an, China. He currently serves as a Clinical Assistant Professor in the Department of Cardiothoracic Surgery at Stanford Hospital and is a surgeon member of the Society of Thoracic Surgeons (STS). Dr. Leon's clinical and research specialties involve the surgical management of cardiopulmonary failure, heart valve disease, and ischemic heart disease, as well as stem cell therapy for myocardial infarction.

  • Mary Leonard

    Mary Leonard

    Arline and Pete Harman Professor and Professor of Medicine (Nephrology) and, by courtesy, of Epidemiology and Population Health

    Current Research and Scholarly InterestsMy multidisciplinary research program is focused on (1) the detrimental effects of glucocorticoids, sarcopenia and inflammation on bone development in pediatric diseases, (2) the long-term effects of childhood cancer on bone and muscle quality, (3) the assessment of renal osteodystrophy using novel micro-imaging techniques, (4) the effects of vitamin D deficiency on physical function and cardiovascular disease, and (5) the evaluation of biomechanical interventions as anabolic bone therapies.

  • Stephanie A. Leonard

    Stephanie A. Leonard

    Assistant Professor (Research) of Obstetrics and Gynecology (Maternal Fetal Medicine) and, by courtesy, of Anesthesiology, Perioperative & Pain Medicine

    BioStephanie Leonard, PhD, MS, is an Assistant Professor in the Dunlevie Maternal-Fetal Medicine Center for Discovery, Innovation, and Clinical Impact (https://dunleviemfm.stanford.edu/). She is also affiliated with the California Maternal Quality Care Collaborative (https://www.cmqcc.org/) and the Stanford Maternal and Child Health Research Institute.

    The goal of Dr. Leonard’s research is to advance equitable, positive health experiences and outcomes for pregnant individuals and newborns. She is interested in applying transdisciplinary methods to perinatal health research, with a focus on studying pregnancy-related morbidities in large data sources. Currently, her primary research interests are in building an infrastructure for distributed data network studies of perinatal health and improving treatment of chronic hypertension in pregnancy. To this end, she co-launched the OHDSI Pregnancy and Reproductive Health Work Group (https://www.ohdsi.org/workgroups/) and collaborates closely with the Harvard Program on Perinatal and Pediatric Pharmacoepidemiology (http://www.harvardpreg.org/). She also serves as a collaborator and mentor on a variety of obstetrics studies, including clinical trials, prospective and retrospective observational studies, and qualitative studies. Dr. Leonard's research program is currently funded by NHLBI (K01) and NICHD (U54).

    Dr. Leonard trained in epidemiology at UCLA (MS) and UC Berkeley (PhD), where her research focused on nutrition in pregnancy and was completed in partnership with the WIC program and the Nutrition Policy Institute. She completed a postdoc in Neonatal and Developmental Medicine at Stanford as part of the Stanford Center for Population Health Sciences.

  • Michael Leong

    Michael Leong

    Clinical Professor, Anesthesiology, Perioperative and Pain Medicine
    Clinical Professor (By courtesy), Neurosurgery

    Current Research and Scholarly Interests- Intrathecal / Intraspinal Analgesics
    - Ziconotide (Prialt)
    - Resiniferatoxin
    - Industry-supported clinical trials

  • John Leppert

    John Leppert

    Professor of Urology and, by courtesy, of Nephrology

    Current Research and Scholarly InterestsOur research aims to improve the global quality of care for patients with Urologic Cancer with a particular focus on kidney cancer. We are investigating novel proteomic platforms and assays to diagnose kidney cancer and predict response to therapy. We are evaluating the comparative effectiveness of various kidney cancer surgeries and their impact on chronic kidney disease and its downstream effects. We are applying epidemiology, bioinformatics, and health services methods to urologic conditions.

  • Ann Leung

    Ann Leung

    Professor of Radiology (Thoracic Imaging)

    Current Research and Scholarly InterestsHigh-resolution computed tomography of the thorax, particularly its application in the setting of acute lung disease in the immunocompromised host; quantitative assessment of abnormalities using thin-section CT; and enhancement characteristics of lung cancers on CT and MRI

  • Kenneth Leung, MD, MS

    Kenneth Leung, MD, MS

    Clinical Assistant Professor, Neurology & Neurological Sciences

    BioDr. Leung is a board-certified neurologist who practices both comprehensive neurology and neuromuscular medicine. He is a Clinical Assistant Professor in the Department of Neurology within the Stanford University School of Medicine.

    Dr. Leung has a particular interest in the diagnosis and management of a broad range of disorders affecting muscle and nerves, including motor neuron disease, neuropathy, neuromuscular junction disorders, and myopathy. He also is an avid clinician educator who develops course work, is involved in education research, and teaches medical students and neurology residents/fellows. He currently serves as Director of the Neurology Clerkship for medical students within the Stanford University School of Medicine.

    He earned his bachelor’s degree from the University of California, Berkeley where he was awarded the 2011 Departmental Citation Award for Excellence in Research in Immunology. In 2016 he earned his medical degree and concurrent master’s degree in applied anatomy from Case Western Reserve University School of Medicine. He then completed his internal medicine internship at Santa Clara Valley Medical Center and neurology residency at the Mount Sinai Hospital in New York. During this time, he developed a passion for neurology education and served on graduate medical education committees for curricular development, trainee well-being and resilience, and quality improvement. For his work in medical education, he was selected as a Harvard Macy Institute Scholar in 2018 and was awarded the 2020 Institute for Medical Education House Staff Excellence in Teaching Award. He was also inducted as a house staff in the Alpha Omega Alpha honor society. He then went on to complete a neuromuscular medicine fellowship at Stanford prior to joining as faculty.-

  • Lawrence Leung

    Lawrence Leung

    Maureen Lyles D'Ambrogio Professor in the School of Medicine

    Current Research and Scholarly InterestsOur long term interest is to have a better understanding of the natural antithrombotic pathways and the pathophysiology of vascular thrombosis. We have focused on thrombin, the key enzyme in the blood clotting cascade.Our goal is to develop new antithrombotic agents and devise new diagnostic tests for vascular thrombotic disorders.

  • Shachar Lev Ari

    Shachar Lev Ari

    Visiting Instructor/Lecturer, Genetics

    BioI am a member and former Chair of the Department of Health Promotion, in the School of Public Health, in the Faculty of Medicine at Tel-Aviv University, former director, and founder of the Integrative Medicine Center & Research Laboratory at the Tel- Aviv Medical Center, and Head of the Health Promotion Unit in the Integrated Cancer Prevention Center. My training is in cellular biology, integrative medicine, intervention research, and health promotion science. I received the Outstanding Israeli Researcher for Complementary and Integrative Medicine award. The goal of my research is to unravel the biology, physiology, and psychology of health promotion approaches and translate findings into interventions that effectively target salutogenic mechanisms underpinning the biopsychology of well-being. I initiated the "lasting change" study and will co-lead this project in my current role as visiting scholar, at Prof. Michael Snyder's Lab, a global leader in precision health at Stanford University.

    https://en.wikipedia.org/wiki/Shahar_Lev-Ari

  • Marc Levenston

    Marc Levenston

    Associate Professor of Mechanical Engineering and, by courtesy, of Radiology (Radiological Sciences Laboratory)

    Current Research and Scholarly InterestsMy lab's research involves the function, degeneration and repair of musculoskeletal soft tissues, with a focus on meniscal fibrocartilage and articular cartilage. We are particularly interested in the complex interactions between biophysical and biochemical cues in controlling cell behavior, the roles of these interactions in degenerative conditions such as osteoarthritis, and development of tissue engineered 3D model systems for studying physical influences on primary and progenitor cells.

  • Craig Levin

    Craig Levin

    Professor of Radiology (Molecular Imaging Program at Stanford/Nuclear Medicine) and, by courtesy, of Physics, of Electrical Engineering and of Bioengineering

    Current Research and Scholarly InterestsMolecular Imaging Instrumentation
    Laboratory

    Our research interests involve the development of novel instrumentation and software algorithms for in vivo imaging of cellular and molecular signatures of disease in humans and small laboratory animal subjects.

  • Eleanor Levin

    Eleanor Levin

    Clinical Professor, Medicine - Cardiovascular Medicine

    Current Research and Scholarly InterestsCardiovascular Value Based Care, Cardio-Obstetrics, Dyslipidemia Treatment

  • Joshua Levin, MD

    Joshua Levin, MD

    Clinical Associate Professor, Orthopaedic Surgery
    Clinical Associate Professor, Neurosurgery

    BioDr. Levin completed a residency in physical medicine and rehabilitation at the University of Michigan in 2007, and a pain medicine fellowship at the Virginia Commonwealth University in 2008. Currently, he is a member of both the departments of orthopedic surgery and neurosurgery at Stanford University, where he also is the director of the PM&R interventional spine fellowship and the director of the PM&R residency program.

  • Deborah J Levine, MD, FCCP, FAST

    Deborah J Levine, MD, FCCP, FAST

    Clinical Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine

    BioDr. Deborah Jo Levine is a board-certified pulmonologist and lung transplantation and pulmonary hypertension specialist. She is a clinical professor of medicine in the Department of Pulmonary, Allergy, and Critical Care Medicine. Dr. Levine also serves as director of lung transplant outreach for Stanford Health Care.

    Dr. Levine is internationally recognized for her work in lung transplantation and pulmonary hypertension (PH). She has been instrumental in developing international guidelines for defining, diagnosing, and managing antibody-mediated rejection (AMR) after lung transplantation. She has served as chair of pulmonary AMR guidelines for the International Society of Heart and Lung Transplantation.

    Dr. Levine’s research interests include lung allograft monitoring and risk assessment. Her research has also included monitoring lung allograft health using donor-derived cell-free DNA (dd-cfDNA)—a technique pioneered at Stanford Medicine. She has received National Institutes of Health (NIH) funding as a clinical investigator. Dr. Levine is a co-chair of the ALAMO (AlloSure Lung Assessment and Metagenomics Outcomes) Study national registry. She has been involved in many clinical trials in lung transplantation and pulmonary hypertension.

    As a respected educator and researcher, Dr. Levine has led and contributed to dozens of abstracts, presentations, and peer-reviewed articles. She has also written several books and book chapters on pulmonary hypertension, interstitial lung disease, pulmonary vascular disorders, and lung transplantation.

    Dr. Levine is editor-in-chief for Advances in Pulmonary Hypertension, the quarterly journal of the Pulmonary Hypertension Association. She is an editorial board member of The Journal of Heart and Lung Transplantation and an ad hoc reviewer for several other industry journals. Dr. Levine also serves as a grant reviewer and section study reviewer for the American College of Chest Physicians and the American Society of Transplantation.

    Dr . Levine is a fellow of the American College of Chest Physicians and the American Society of Transplantation. She is also the chair of the Diffuse Lung Disease and Lung Transplant Network and the incoming vice chair of the Council of Networks for the American College of Chest Physicians (CHEST).

  • Douglas F. Levinson, M.D.

    Douglas F. Levinson, M.D.

    Walter E. Nichols, M.D. Professor in the School of Medicine, Emeritus

    Current Research and Scholarly InterestsDr. Levinson directs the Program on the Genetics of Brain Function in the Department of Psychiatry and Behavioral Sciences. The program investigates the genetic basis of psychiatric disorders (schizophrenia and major depressive disorder), using genetic association, linkage and resequencing methodologies. In collaboration with Dr. Alice Whittemore, we are also actively engaged in statistical methods testing and development for genetic research.

  • Joseph Levitt, MD, MS

    Joseph Levitt, MD, MS

    Associate Professor of Medicine (Pulmonary and Critical Care Medicine)

    Current Research and Scholarly InterestsMy research focuses on the physiolgogic and biomarker characteristics of early acute lung injury (ALI) prior to need for mechanical ventilation. While, to date no pharmacologic treatment has improved survival in ALI, following the paradigm of early goal directed therapy for severe sepsis, clinical benefit may derive from identifying patients and initiating treatment prior to the need for positive pressure ventilation (and therefore prior to meeting current study entry criteria).

  • Lee Levitt

    Lee Levitt

    Professor of Medicine (Hematology) at the Santa Clara Valley Medical Center, Emeritus

    Current Research and Scholarly InterestsLow molecular-weight heparins Clinical trials with anti-thrombotics Clinical trials in patients with leukemia, breast cancer and myeloma Medical education.

  • Michael Levitt

    Michael Levitt

    Robert W. and Vivian K. Cahill Professor of Cancer Research and Professor, by courtesy, of Computer Science

    Current Research and Scholarly InterestsStanford Professor of Biophysics and Computational Biology, Cambridge PhD and DSc, 2013 Chemistry Nobel Laureate (complex systems), FRS & US National Academy member, I code well for my age.

  • Ronald Levy, MD

    Ronald Levy, MD

    Robert K. and Helen K. Summy Professor in the School of Medicine

    Current Research and Scholarly InterestsClinical Interests: lymphoma. Research Interests: Immunology and molecular biology of lymphoid malignancy; molecular vaccines for cancer.

  • David B. Lewis

    David B. Lewis

    Naddisy Foundation Professor of Pediatric Food Allergy, Immunology, and Asthma

    Current Research and Scholarly InterestsMy laboratory is focused on defining cellular and molecular mechanisms that limit T cell responses to vaccines and pathogens during normal early postnatal development and in cases of inherited genetic immunodeficiencies. We are also determinomg how these limitations in immunity can be overcome by using novel approaches for vaccine adjuvants for influenza vaccine and by using catalytically inactive Cas proteins for inducing endogenous gene expression.

  • Eldrin F. Lewis, MD, MPH

    Eldrin F. Lewis, MD, MPH

    Simon H. Stertzer, MD, Professor

    BioDr. Lewis is a board-certified, fellowship-trained specialist in cardiovascular medicine. He is the chief of the Division of Cardiovascular Medicine and a professor of cardiovascular medicine.

    Dr. Lewis is an esteemed clinician-scientist who specializes in the care of patients with advanced heart failure. He is an internationally recognized expert on heart failure, heart transplant, and quality of life for heart failure patients. He cares deeply about his patients as well as his colleagues, the hospital, and the School of Medicine. Dr. Lewis is committed to diversity and inclusion, as well as expanding Stanford clinical research initiatives.

    A fundamental principle of Dr. Lewis’ practice is his belief that “there is more to life than death,” that cardiovascular care should go beyond helping patients survive to also helping them enjoy the best possible quality of life.

    Dr. Lewis has deep expertise in conducting clinical trials examining diagnostic and therapeutic approaches to heart failure. He has done innovative work to create systems for incorporating quality of life measures for cardiovascular patients into electronic health records. This research has received support from the National Heart, Lung and Blood Institute and the National Institutes of Health.

    Much of his quality of life research has focused on patient-reported outcomes. Dr. Lewis emphasizes the importance of looking at how a disease, whether chronic or acute, impacts people’s ability to function and perform their activities of daily living. Strategies to improve patients’ well-being focus not only on their physical symptoms but also on depression, anxiety, exercise capacity, and ability to function in daily living.

    Dr. Lewis’ commitment to expanding clinical research initiatives will give patients more opportunities to participate in the clinical trials and access the latest care strategies that can translate into better outcomes. The goal is early access to the most advanced technology, pharmacology, and device therapy that can change outcomes for the better. He also envisions forming closer partnerships with community cardiologists and capitalizing further on Stanford’s proximity to and unique relationships with the digital technology leaders of Silicon Valley to enhance the use of digital technology for monitoring patients, optimizing treatment, and tracking outcomes.

    He has authored nearly 200 articles published in peer-reviewed journals including the New England Journal of Medicine, Journal of the American College of Cardiology, Circulation, JAMA Cardiology, JAMA Internal Medicine, and many more. He is also on multiple editorial boards for cardiovascular journals and was an associate editor for Circulation–Heart Failure. In addition, he is an author of professional society clinical practice guidelines and scientific statements from both the American Heart Association (AHA) and the Food and Drug Administration.

    Dr. Lewis’ honors for clinical care, scholarship, and research include the Joel Gordon Miller Award for community service and leadership from the University of Pennsylvania School of Medicine. He also was one of the first recipients of the Minority Faculty Development Award, which recognizes the research potential of young physicians. Dr. Lewis has received a grant from the Robert Wood Johnson Foundation to study the role of quality of life assessment in clinical decision making in patients with heart failure.

    He is a fellow of the American College of Cardiology and the National American Heart Association (AHA) Research Committee. In addition, Dr. Lewis was as a member of the AHA Founders Affiliate Board of Directors, chair of the Council on Clinical Cardiology, and research chair of the Association of Black Cardiologists. He also serves on scientific committees to review grants for the AHA and on the FDA Task Force for the Standardization of Definitions for Endpoint Events in Cardiovascular Trials.

  • Matthew Lewis, MD, MPH

    Matthew Lewis, MD, MPH

    Clinical Associate Professor, Dermatology

    BioDr. Lewis specializes in autoimmune connective tissue diseases, immunobullous diseases, and other inflammatory skin diseases including psoriasis and sarcoidosis. He completed medical school at The George Washington University School of Medicine and dermatology residency at The University of Rochester, where he was chief resident. He also completed a Master’s of Public Health at Johns Hopkins and a fellowship in autoimmune connective tissue diseases at Stanford University.

    He believes multidisciplinary and holistic care is key to treat patients with systemic inflammatory diseases. He holds a rheumatology-dermatology clinic with a rheumatologist, Dr. Janice Lin, as well as a dermatology-ophthalmology clinic with an ophthalmologist, Dr. Christopher Ta, and is the dermatologist for the sarcoidosis program, all with this primary goal of providing high quality, collaborative, patient-centered care.

  • Richard Lewis

    Richard Lewis

    Professor of Molecular and Cellular Physiology

    Current Research and Scholarly InterestsWe study molecular mechanisms of calcium signaling with a focus on store-operated CRAC channels and their essential roles in T cell development and function. Currently we aim to define the molecular mechanism for CRAC channel activation and the means by which calcium signal dynamics mediate specific activation of transcription factors and T-cell genes during development.

  • Dayan Li

    Dayan Li

    Clinical Scholar, Dermatology
    Postdoctoral Scholar, Pediatric Surgery

    Current Research and Scholarly InterestsWound healing, cutaneous fibrosis

  • Gordon Li, MD

    Gordon Li, MD

    Professor of Neurosurgery and, by courtesy, of Neurology and of Otolaryngology - Head & Neck Surgery (OHNS)

    Current Research and Scholarly Interests1.) My laboratory studies the biology of brain tumors with the goal of developing novel therapeutics for the treatment of malignant brain tumors and translating that research into clinical trials.
    2.) My clinical interests include improving surgical techniques for brain tumor surgery, immunotherapy for the treatment of glioblastoma, and novel uses for stereotactic radiosurgery.

  • Jin Billy Li

    Jin Billy Li

    Professor of Genetics

    Current Research and Scholarly InterestsThe Li Lab is primarily interested in RNA editing mediated by ADAR enzymes. We co-discovered that the major function of RNA editing is to label endogenous dsRNAs as "self" to avoid being recognized as "non-self" by MDA5, a host innate immune dsRNA sensor, leading us to pursue therapeutic applications in cancer, autoimmune diseases, and viral infection. The other major direction of the lab is to develop technologies to harness endogenous ADAR enzymes for site-specific transcriptome engineering.

  • Lingyin Li

    Lingyin Li

    Associate Professor of Biochemistry

    BioDr. Li is an associate professor in the Biochemistry Department and ChEM-H Institute at Stanford since 2015. Her lab works on understanding biochemical mechanisms of innate immunity and harnessing it to treat cancer. She majored in chemistry at University of Science and Technology of China and graduated with a B. En in 2003. She then trained with Dr. Laura Kiessling, a pioneer in chemical biology, at University of Wisconsin-Madison and graduated with a Ph.D in chemistry in 2010. She obtained her postdoctoral training with Dr. Timothy Mitchison at Harvard Medical School, who introduced her to the field of chemical immunology.

  • Ron Li

    Ron Li

    Clinical Associate Professor, Medicine

    BioRon Li is a Clinical Associate Professor of Medicine in the Division of Hospital Medicine and Center for Biomedical Informatics Research at Stanford University School of Medicine. As the Medical Informatics Director for Digital Health at Stanford Health Care, he provides medical and informatics direction for the health system's enterprise digital health portfolio, including expanding digital referral networks and virtual care modalities. He is the co-founder and Director for the Stanford Emerging Applications Lab (SEAL), which helps clinicians and staff build ideas into novel digital products that are prototyped and tested for care delivery at Stanford Health Care.

    Ron's academic interests focus on the "delivery science" of new technological capabilities such as digital and artificial intelligence in healthcare and how to design, implement, and evaluate new tech enabled models of care delivery. Ron's work spans across multiple disciplines, including clinical medicine, data science, digital health, information technology, design thinking, process improvement, and implementation science. He has consulted for various companies in the digital health and artificial intelligence space and is leading work in AI and user experience research in partnership with Google. He is an attending physician on the inpatient medicine teaching service at Stanford Hospital and is a core faculty for the Stanford Clinical Informatics Fellowship.

  • Ruijiang Li

    Ruijiang Li

    Associate Professor (Research) of Radiation Oncology (Radiation Physics)

    Current Research and Scholarly InterestsMy lab's research is focused on the development of imaging and molecular biomarkers to improve cancer detection, diagnosis, prognostication, and prediction of therapy response. Our ultimate goal is to translate these biomarkers into clinical practice to guide optimal management and therapeutic decisions for precision cancer medicine.

  • Yi Li, MD, PhD

    Yi Li, MD, PhD

    Clinical Assistant Professor, Neurology & Neurological Sciences

    BioDr. Li is a board-certified, fellowship-trained neurologist and a clinical assistant professor in the Department of Neurology and Neurological Sciences at Stanford University School of Medicine.

    She specializes in epilepsy care and research. She has dedicated her career to advancing our understanding of the mechanism, diagnosis, and treatment of epilepsy. In addition to her MD degree, she holds a PhD degree in neurology and neuroscience. She undertook PhD training to better understand epileptogenesis and to identify potential new treatments for refractory epilepsy patients. She has received the Stanford Genetics and Genomics Certificate, which helped advance her knowledge of how genomic data can enhance patient management in clinical practice.

    She has published numerous articles on a wide range of epilepsy-related topics. Among her honors, Dr. Li has earned recognition from the American Epilepsy Society and International League Against Epilepsy. She also won a safety and quality awards scholarship from the American Academy of Neurology. She is a member of the American Academy of Neurology and the American Epilepsy Society.

  • Kif Liakath-Ali

    Kif Liakath-Ali

    Instructor, Molecular & Cellular Physiology

    BioDr Liakath-Ali holds a PhD degree in molecular genetics from the University of Cambridge, UK. He carried out his doctoral and a brief post-doctoral research under the supervision of Professor Fiona Watt at Cambridge and King’s College London. While in Watt lab, he conducted a first, large-scale tissue-specific phenotype screen on hundreds of knockout mice and discovered many novel genes that are essential for mammalian skin function. He further elucidated the mechanistic roles of sphingolipid and a ribosome-rescue pathway in epidermal stem cell function. He has published many papers in the area of skin biology and won several awards, including, most recently a long-term fellowship from the European Molecular Biology Organization (EMBO) and postdoctoral/principal investigator grant from the Larry L Hillblom Foundation.

    Dr Liakath-Ali obtained his bachelor and master degree in Zoology from Jamal Mohamed College (Bharathidasan University), Trichy, India. He further specialized in human genetics and obtained an MPhil from the University of Madras, India. He went on to work at various capacities at the Centre for DNA Fingerprinting and Diagnostics, Hyderabad, India, Institute of Human Genetics, University of Göttingen, Germany and the Wellcome Sanger Institute, Cambridge, UK. Dr Liakath-Ali also holds a degree equivalent (Associateship of King’s College (AKC) in Philosophy, Ethics and Theology, awarded by King's College London, UK.

    It is perhaps these combinations of diverse backgrounds and training that led Dr Liakath-Ali to develop an interest in fundamental questions in neuroscience. He is currently an EMBO & Hillblom Fellow, working under the mentorship of Professor Thomas Südhof at Stanford on genetic mechanisms involved in synapse formation and function. He is also an avid communicator of science, eLife Community Ambassador, STEM Ambassador and Ambassador for open science, research rigor and reproducibility.

  • David Liang, MD, PhD

    David Liang, MD, PhD

    Professor of Medicine (Cardiovascular) at the Stanford University Medical Center, Emeritus

    BioStanford researchers are creating a micro-device that physicians could guide through the body to help diagnose and treat clogged arteries and other diseases. Tethered to the outside world by a thin wire, a tiny machine creeps through blood vessels, searching out deadly plaques and obliterating them with a zap of a laser. While a laser will come later, for now David Liang, MD, PhD, is focusing on a tiny eye that could give physicians an unprecedented view into blood vessels.

  • Charles Liao

    Charles Liao

    Clinical Assistant Professor, Medicine

    Current Research and Scholarly InterestsEducational Curriculum: Working with Professional Interpreters

  • Congyu Liao

    Congyu Liao

    Instructor, Radiology

    BioCongyu Liao is an Instructor in the Division of Radiological Sciences Laboratory (RSL). Dr. Liao received his PhD in Biomedical Engineering from Zhejiang University in China in 2018. Following the completion of his PhD, he was appointed Postdoctoral Research Fellow at Massachusetts General Hospital/Harvard University under Kawin Setsompop, PhD, where his research was focused on improving the efficiency of data acquisition/reconstruction in MRI. In 2021, he came to Stanford to join Dr. Setsompop’s lab as a Postdoctoral Scholar in RSL where his research is focused on developing new technology for diffusion and quantitative MRI. Dr. Liao has received many awards including the Summa Cum Laude Merit Award from the International Society for Magnetic Resonance in Medicine and the Outstanding Research Award from the Overseas Chinese Society for Magnetic Resonance in Medicine.

  • Joseph C. Liao

    Joseph C. Liao

    Kathryn Simmons Stamey Professor

    Current Research and Scholarly InterestsThe overarching theme of my scholarship is to develop precision diagnostics in imaging and biomarkers to guide the delivery of precision therapy for urological diseases including bladder cancer, urinary tract infections, and kidney stone disease.

  • Ronglih Liao

    Ronglih Liao

    Douglass M. and Nola Leishman Professor of Cardiovascular Disease

    BioDr. Liao is a Professor of Medicine and co-Director of Stanford Cardiac Amyloid Center. The major goal of her research program focuses on understanding the mechanisms that underlie the pathophysiology of heart failure and developing novel treatments to combat this process. Her laboratory has played an international leading role in the study of amyloid light chain (AL) cardiomyopathy, a rare and fatal form of cardiovascular disease. We have described the underlying pathophysiologic basis for amyloid cardiomyopathy and found that the circulating amyloidogenic light chain proteins that characterize this disease directly result in a specific cardiotoxic response. Consequently, our research work has redefined AL cardiomyopathy and has raised new treatment approaches. More recently, her research efforts have expanded to include transthyretin (ATTR) cardiac amyloidosis.

    In line with her goal of revealing novel therapeutic strategies for patients with cardiovascular disease, our efforts have also focused on characterizing and harnessing endogenous cardiac regenerative mechanisms. Her laboratory initially demonstrated the therapeutic potential of exogenous primitive muscle cells delivered to the injured heart. This work was among the earliest milestones in the field and served as the basis for an international trial of cell-based therapy. Subsequently, Liao lab identified and characterized a population of cardiac progenitor cells and its relationship and dynamic activity following cardiac injury in the adult heart. Her laboratory aims to reveal the molecular mechanisms regulating the endogenous regenerative capacity of the heart and to harness such repair mechanisms for the treatment of cardiovascular disease. Dr. Liao has lectured extensively on both amyloid cardiomyopathy and stem cell biology, and have maintained a history of independent NIH funding in these areas for more than two decades.

    Over the course of her academic career, she has taken the greatest pride in mentoring the next generation of scientists. Dr. Liao has had the privilege to supervise several dozen students, postdoctoral fellows, and junior faculty, many of whom have gone on to independent academic careers at the highest institutions. Her contribution to the advancement of scientific knowledge also includes lecturing at various university and academic institutions as well as at scores of conferences and symposia locally, nationally, and internationally.

  • Y. Joyce Liao, MD, PhD

    Y. Joyce Liao, MD, PhD

    Stanford Medicine Professor of Ophthalmology and Professor of Neurology

    Current Research and Scholarly InterestsIschemic optic neuropathy
    Stem cell transplantation
    Optic neuropathy
    Optic neuritis
    Eye movement disorders
    Reading
    Parkinson's disease
    Multiple sclerosis

  • Yungting Liao

    Yungting Liao

    Clinical Associate Professor, Pediatrics

    Current Research and Scholarly Interestsclinical informatics, quality improvement

  • Cara A. Liebert, MD, FACS

    Cara A. Liebert, MD, FACS

    Clinical Assistant Professor, Surgery - General Surgery

    Current Research and Scholarly InterestsCurrent research interests include Surgical Education and Minimally Invasive Surgery. Primary research focus is the development, implementation, and collection of validity evidence for ENTRUST, an online virtual patient simulation platform for assessment of clinical decision-making.

  • Michaela Liedtke

    Michaela Liedtke

    Associate Professor of Medicine (Hematology)

    Current Research and Scholarly Interests1) Design of phase I/II trials for the treatment of Multiple Myeloma and Amyloidosis

    2) Conduct of clinical trials to improve the treatment of patients with acute lymphoblastic leukemia (ALL)

    3) Outcomes research using clinical databases for patients with Multiple Myeloma and Amyloidosis

  • Geoffrey Lighthall

    Geoffrey Lighthall

    Professor of Anesthesiology, Perioperative and Pain Medicine (Adult MSD)

    Current Research and Scholarly InterestsResearch Interests

    I1. Care of the critically ill outside of the ICU
    A. Development and evaluation of Medical Emergency Teams (aka. Rapid
    Response Teams)
    B. Detecting deterioration of non-ICU patients
    C. Cardiac arrest teams

    II. Training for patient care crises -- emphasis on use of patient simulation methods
    A. ICU team training
    B. Simulation in medical student ICU education
    C. Resuscitation skills for code blue and RRT responses

  • Theresa Lii, M.D., M.S.

    Theresa Lii, M.D., M.S.

    Clinical Scholar, Anesthesiology, Perioperative and Pain Medicine
    Postdoctoral Scholar, Anesthesiology, Perioperative and Pain Medicine

    Current Research and Scholarly InterestsEvaluating the analgesic and antidepressant effects of ketamine in humans

  • Michael Lim, M.D.

    Michael Lim, M.D.

    Professor of Neurosurgery and, by courtesy, of Radiation Oncology (Radiation Therapy), of Medicine (Oncology), of Otolaryngology - Head & Neck Surgery (OHNS) and of Neurology

    BioDr. Lim is the Chair of the Department of Neurosurgery and a board-certified neurosurgeon specializing in brain tumors and trigeminal neuralgia.

    Dr. Lim’s clinical interests include the treatment of benign and malignant brain tumors, with special interest in gliomas, meningiomas, metastatic tumors, and skull base tumors. Dr. Lim also specializes in surgical treatments for trigeminal neuralgia. During his time at Johns Hopkins, Dr. Lim built one of the largest brain tumor and trigeminal neuralgia practices and utilized the most advanced surgical technologies and techniques for his patients. As a passionate voice for patient experience, he has been recognized by his peers and patients for his integrity and compassionate care, including a Service Excellence Award from HealthNetwork Foundation.

    As a mentor, he has garnered numerous teaching awards, including being honored as an outstanding teacher by Johns Hopkins University School of Medicine. He is actively involved in shaping education for neurosurgery and oncology across the United States and around the world. He is the recipient of the prestigious 2023 Abhijit Guha Award in Neuro-Oncology.

    Dr. Lim’s research interests focus on harnessing the immune system to fight cancer. His laboratory focuses on understanding mechanisms of immune evasion by cancer cells. He has successfully translated his findings from the laboratory to the clinics and has conducted and led several large national immunotherapy clinical trials for brain tumors.

    Dr. Lim’s bibliography contains well over 300 articles on topics such as immunotherapy for glioblastoma, long-term survival of glioma patients treated with stereotactic radiation, and treatment of neuropathic pain. His work has appeared in Science Translational Medicine, Clinical Cancer Research, Lancet Oncology, Nature Immunology, and many more publications. He also has written 20 book chapters and monographs.

    Dr. Lim is a world leader in immunotherapy for brain tumors. In addition to being invited world-wide to give lectures and seminars, he has given platform presentations on the topics of immunotherapy for brain tumors, neurosurgical techniques and management of brain tumors at the American Society of Clinical Oncologists, American Academy of Neurological Surgeons, Radiological Society of North America, Annual Symposium on Brain and Spine Metastases, Congress of Neurological Surgeons, and other meetings. In addition, he has served as platform chairman of the CNS session at the American Society for Clinical Oncology conference.

    Dr. Lim is a member of the American Society for Clinical Oncology, Congress of Neurological Surgeons, American Association of Neurological Surgeons, and Society for Neuro-Oncology. Dr. Lim served as the program co-chair of the Society for Neuro-Oncology and CNS section of the American Society for Clinical Oncology. He also served on many executive committees, including the Executive Committee for the Joint Tumor Section of the American Association of Neurological Surgeons and Congress of Neurological Surgeons.

  • David Limsui

    David Limsui

    Clinical Professor, Medicine - Gastroenterology & Hepatology

    BioThroughout my career I have been extensively involved in post-graduate medical education and training of residents and fellows. I served on the AGA Future Trends Committee tasked with reporting the future of gastroenterology training programs and have been admitted into the AGA Academy of Educators. I joined Stanford for the incredible opportunity to be part of a dynamic division with excellent and dedicated faculty where one can achieve their greatest potential. I share the honor and privilege of leading our fellowship program and in the joy of teaching such talented and inspiring fellows. Together we strive to provide the best educational experience for our fellows to become outstanding gastroenterologists and future leaders in academic medicine.
    My subspecialty areas of focus are inflammatory bowel disease and general gastroenterology.

  • Bryant Lin

    Bryant Lin

    Clinical Professor, Medicine - Primary Care and Population Health

    Current Research and Scholarly Interests-Digital Health
    -Medical device design, prototyping, testing and clinical trials
    -Behavioral determinants of chronic disease
    -Novel diagnostic processes for medical mysteries
    -Asian Health
    -Medical Humanities and Arts
    -Medical Technology

  • Charles C. Lin, MD

    Charles C. Lin, MD

    Clinical Associate Professor, Ophthalmology

    Current Research and Scholarly InterestsDr. Lin conducts clinical trials focused on cornea transplantation, corneal edema, and cornea infections at Stanford. His research interests include improving the success and safety of cutting edge surgeries such as ultra-thin DSAEK, DMEK, DALK, and DSO. He is actively researching surgical therapies for corneal edema and Fuchs' Dystrophy. He is among a handful of cornea specialists nationwide with extensive experience using intraoperative OCT imaging to perform cornea transplants.

  • Dana Lin, MD

    Dana Lin, MD

    Clinical Associate Professor, Surgery - General Surgery

    BioDr. Lin is a fellowship-trained endocrine surgeon who specializes in surgery of the thyroid, parathyroid, and adrenal glands. After receiving her undergraduate degree from Stanford University, Dr. Lin pursued her medical and surgical training on the east coast, where she completed her residency in general surgery at Rutgers Robert Wood Johnson Medical School and fellowship in endocrine surgery at the Harvard-affiliated Massachusetts General Hospital.

    Dr. Lin's clinical practice focuses on the surgical management of benign and malignant thyroid conditions, hyperparathyroidism, adrenal tumors, as well as melanoma and advanced skin cancers. She is skilled in mini-incision, minimally invasive (laparoscopic), and remote access (scarless endoscopic) surgery as well as lymph node dissection for cancer. She currently serves as Director of the Parathyroid Center within the Endocrine Oncology Program at Stanford.

    Dr. Lin strives to deliver expert surgical care to patients with utmost humanism and compassion. She considers it a privilege and joy to be entrusted as one’s surgeon and is committed to ensuring the best clinical and cosmetic outcome for each of her patients. Dr. Lin welcomes patients at Stanford Cancer Center in Palo Alto as well as Stanford Health Care in Emeryville and Pleasanton (ValleyCare).

  • Feng Vankee Lin

    Feng Vankee Lin

    Clinical Professor, Psychiatry and Behavioral Sciences

    Current Research and Scholarly InterestsMy career has been devoted to understanding the neural mechanisms involved in brain aging and brain plasticity, with a special focus on early detection and prevention of Alzheimer’s disease (AD). My research approach integrates principles and findings from cognitive theory, clinical neuroscience, and computational neuroscience.

  • Janice Lin

    Janice Lin

    Clinical Assistant Professor, Medicine - Immunology & Rheumatology

    BioDr. Lin specializes in the diagnosis and treatment of rheumatologic conditions such as rheumatoid arthritis, lupus, myositis, gout, and seronegative spondyloarthropathies. She received additional training in autoimmune skin diseases and has a special clinical and research interest for psoriasis/psoriatic arthritis, dermatomyositis, cutaneous lupus/systemic lupus. She leads a combined rheumatology-dermatology clinic with Dr. Matthew Lewis in the dermatology department to take care patients collaboratively. Dr. Lin is a graduate of USSONAR (Ultrasound School of North American Rheumatologists) program and performs diagnostic musculoskeletal ultrasound evaluation and interventions. In addition to her clinical work, she leads the quality improvement effort for the division and her most recent projects are focused on patient-reported outcome in rheumatoid arthritis and vaccinations for patients in the rheumatology clinic.

  • Kathie S Lin

    Kathie S Lin

    Clinical Assistant Professor, Neurology & Neurological Sciences

    BioDr. Lin practices both Neuromuscular Medicine and Comprehensive Neurology in Emeryville and Palo Alto. She has a particular interest in the diagnosis and management of neuromuscular disease including neuromuscular junction disorders, motor neuron disease, and focal neuropathy. Additionally, she is interested in medical education and developing a practical framework for teaching neurology and neurophysiology to medical students and neurology residents.

    She earned her medical degree at the University of Pittsburgh School of Medicine where was awarded a Dean's Scholarship and the Dr. Tryphena Humphrey Student Award in Neurology. She completed neurology residency at the Harvard Neurology Program at the Beth Israel Deaconess Medical Center in Boston where she served as an administrative chief resident in her final year and was awarded the Michael Ronthal Resident Teaching Award. She then went on to complete her neuromuscular medicine fellowship at Stanford.

  • Kenneth Michael Lin, MD

    Kenneth Michael Lin, MD

    Clinical Assistant Professor, Orthopaedic Surgery

    BioDr. Kenneth Lin is an orthopaedic surgeon and clinical assistant professor at Stanford University School of Medicine. He specializes in sports medicine. Dr. Lin has clinical expertise in minimally invasive and reconstructive techniques of the knee, shoulder, and elbow. As a former college athlete, he understands the demands and challenges facing athletes of all ages and competition levels.

    Following his undergraduate studies at Massachusetts Institute of Technology, Dr. Lin attended medical school at Washington University in St. Louis. He attended residency at the renowned Hospital for Special Surgery in New York City. Upon graduation, Dr. Lin received the Thomas P. Sculco Award, selected by hospital staff, for exemplary service and exceptional core values. In addition, his peers selected him to receive the Jean C. McDaniel Award for leadership, professionalism, and ethics in patient care. As a Sports Medicine fellow at Stanford, Dr. Lin received special training in complex knee, shoulder, elbow, and hip conditions.

    He treats chronic conditions, sports injuries, and traumatic injuries affecting the arm and leg. Dr. Lin has expertise in treating complex knee, shoulder, and elbow conditions, as well as injuries of the hip and ankle. He specializes in joint preservation, tendon/ligament repair and reconstruction, cartilage restoration, and fracture care. Dr. Lin uses nonsurgical, arthroscopic and traditional open surgery techniques. He takes a minimally invasive approach to achieve the greatest recovery with the least invasive treatment.

    Dr. Lin has academic research interests in the clinical, basic science, and biomechanical foundations of injury, healing, and rehabilitation. He continues to participate in clinical outcomes research and laboratory research. His research focus is developing new surgical techniques and harnessing emerging technologies for both surgical and nonsurgical treatment. He also has special interest in understanding the biological basis of healing and regeneration of tendons, ligaments, and cartilage.

    He has presented at numerous regional, national, and international conferences. He has authored or co-authored over 30 peer-reviewed publications and textbook chapters.

    Dr. Lin is a Bay Area native who enjoys surfing, traveling, and being outdoors. He loves coaching, playing, and watching sports. Dr. Lin has provided medical coverage for various types of sporting events. He has also served as a team physician for multiple high schools and junior colleges. Dr. Lin previously served as the assistant team physician for Stanford University Athletics.

  • Margaret Chin-Chin Lin

    Margaret Chin-Chin Lin

    Clinical Associate Professor, Radiology

    BioDr. Margaret Lin is a board certified radiologist with subspecialty training in thoracic and cardiovascular imaging. Dr. Lin specializes in diseases affecting the lungs and airways, including cancer, infection, and interstitial and inhalational lung diseases. Her clinical expertise also includes diseases of the cardiovascular system, such as coronary artery disease, aortic dissection and aneurysm, and pulmonary thromboembolic disease. As an Associate Program Director for the Diagnostic Radiology Residency at Stanford, Dr. Lin focuses on resident education and development of curricula and new educational tools.

  • Michael Lin

    Michael Lin

    Associate Professor of Neurobiology, of Bioengineering and, by courtesy, of Chemical and Systems Biology

    Current Research and Scholarly InterestsOur lab applies biochemical and engineering principles to the development of protein-based tools for investigating biology in living animals. Topics of investigation include fluorescent protein-based voltage indicators, synthetic light-controllable proteins, bioluminescent reporters, and applications to studying animal models of disease.

  • Michelle P. Lin

    Michelle P. Lin

    Associate Professor of Emergency Medicine (Adult Clinical/Academic)

    Current Research and Scholarly InterestsDr. Lin's active NIH-funded research portfolio includes developing a novel patient-reported outcome measure for emergency asthma care; evaluating post-acute transitions and outcomes for high-risk populations; and enhancing health professions workforce diversity and retention. Her prior funded projects have evaluated the impact of value-based care on emergency care delivery and payment; drivers of ED admission rates; and changes in the intensity of emergency care.

  • Stacy Lin

    Stacy Lin

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    BioDr. Stacy Lin is a licensed psychologist in the Department of Psychiatry and Behavioral Sciences who provides culturally-informed psychotherapy for the treatment of emotion dysregulation, eating disorders, and trauma. Dr. Lin has specialized training in comprehensive Dialectical Behavior Therapy and Cognitive Behavioral Therapy. She is broadly interested in issues of diversity and inclusion in clinical, training, and professional settings. Her research has examined cultural factors affecting disordered eating and body image in racial/ethnic minorities.

  • Steven Lin

    Steven Lin

    Clinical Professor, Medicine - Primary Care and Population Health

    Current Research and Scholarly InterestsArtificial intelligence and machine learning in healthcare
    Primary care and population health
    Value added medical education

  • Yihan Lin, MD MPH

    Yihan Lin, MD MPH

    Clinical Assistant Professor, Cardiothoracic Surgery

    BioDr. Lin is a cardiothoracic surgeon and clinical assistant professor in the Department of Cardiothoracic Surgery at Stanford University School of Medicine. She provides the complete spectrum of surgical care for cardiac conditions, including ischemic heart disease, structural heart disease, aortic disease, and arrhythmias.

    Dr. Lin's research is focused on surgical education and global disparities in surgical care. She obtained her Master of Public Health from the Harvard School of Public Health. Her research aims to decrease barriers and disparities in surgical care, including in low and middle income settings.

  • Brian Linde, MD

    Brian Linde, MD

    Clinical Assistant Professor, Medicine - Primary Care and Population Health

    BioDr. Linde is a double board-certified, fellowship-trained internal medicine doctor with the Department of Medicine, Division of Primary Care & Population Health at Stanford University School of Medicine. He is board certified in both internal medicine and occupational and environmental medicine. He is fellowship trained in occupational and environmental medicine.

    Dr. Linde specializes in preventing, managing, and treating work-related injuries and diseases. He uses his expertise to improve the physical and mental wellness of his patients while reducing their exposure to occupational and environmental hazards. As a public health expert, Dr. Linde also focuses on enhancing the health of entire populations through strategies and policies that benefit communities as a whole.

    His academic interests include inhalational exposures and occupational lung diseases. During the COVID-19 pandemic, Dr. Linde studied how to increase adherence to infection prevention recommendations in clinical settings. He has also worked on guidance related to exposure to per- and polyfluoroalkyl substances (PFAS). These chemicals, which are found in water, food, and fabrics, are an ongoing public health concern. Dr. Linde has also researched how to improve the mental and physical health of medical students and ways to prevent physician burnout.

    Dr. Linde has published in many peer-reviewed journals, including Current Opinion in Pulmonary Medicine and Academic Medicine. As a member of the Committee on the Guidance on PFAS Testing and Health Outcomes, Dr. Linde contributed to Guidance on PFAS Exposure, Testing, and Clinical Follow-Up, a publication of the National Academies of Sciences, Engineering, and Medicine. He was also a reviewer for Archives of Environmental & Occupational Health and the American Journal of Industrial Medicine.

    He has written book chapters for Modern Occupational Diseases: Diagnosis, Epidemiology, Management and Prevention and Patty’s Industrial Hygiene. He wrote about preventing occupational and environmental pulmonary disorders for the Merck Manuals Professional Edition. Dr. Linde has been invited to speak at workshops and presentations all over the nation about a range of topics, including environmental health risks in underserved communities and the health effects of floods.

    Dr. Linde is a member of the American Board of Internal Medicine and the American Board of Preventive Medicine. He is also a member of the American College of Physicians and the American College of Occupational and Environmental Medicine.